Docetaxel is a crucial chemotherapy drug (an antineoplastic agent) used to treat various types of cancer, including breast, prostate, and lung cancers. The synthesis process typically involves deprotection and acylation steps to convert the intermediate into the final active compound. 7,10-di-Troc-Docetaxel is an intermediate employed to synthesize the active pharmaceutical ingredient (API) Docetaxel.
7,10-di-Troc-Docetaxel
| API Name | Docetaxel |
|---|---|
| Molecular Formula | C49H55Cl6NO18 |
| Molecular Weight | 1158.7 g/mol |
| Synonyms | [4-acetyloxy-1-hydroxy-15-[2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-9,12-bis(2,2,2-t -Show More |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
Docetaxel is a crucial chemotherapy drug (an antineoplastic agent) used to treat various types of cancer, including breast, prostate, and lung cancers. The synthesis process typically involves deprotection and acylation steps to convert the intermediate into the final active compound. 7,10-di-Troc-Docetaxel is an intermediate employed to synthesize the active pharmaceutical ingredient (API) Docetaxel.
The molecular formula of 7,10-di-Troc-Docetaxel is C49H55Cl6NO18.
The listed molecular weight of 7,10-di-Troc-Docetaxel is 1158.7 g/mol.
7,10-di-Troc-Docetaxel is listed as being used in connection with the following API: Docetaxel.
The listed synonym or IUPAC name for 7,10-di-Troc-Docetaxel is [4-acetyloxy-1-hydroxy-15-[2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-9,12-bis(2,2,2-t -Show More.